| Alnylam and Cubist form R&D collaboration (Pharmaceutical Business Review) |
|
|
Alnylam Pharmaceuticals, an RNAi therapeutics company, and Cubist Pharmaceuticals, an acute care biopharmaceutical company, have formed a strategic collaboration to develop and commercialize Alnylams ALN-RSV program. |